The Role of MSLs in Achieving Health Equity

In this episode, Ariel Katz, co-founder of H1, joins Tom Caravela to discuss the crucial topic of health equity. Ariel shares insights into his background and the mission of H1, defining health equity and exploring the causes of healthcare inequity. The conversation delves into the roles of MSLs and leadership in promoting health equity and highlights the actions pharmaceutical companies can take, emphasizing patient advocacy. The discussion also covers the impact of stricter FDA regulations on future MSL engagement and the importance of engaging with low and middle-income communities. Ariel offers final thoughts on raising awareness and building trust in healthcare.

My guest today is Ariel Katz, CEO and Founder of H1 and we discuss the role of MSLs in achieving Health Equity.

This episode is sponsored by H1, for info please visit www.H1.co

Ariel shares…

👉 His definition of health equity and why it has become a problem
👉 How MSLs fit into the equation for health equity and what can they do
👉 What pharma and biotech companies can do to assist in this effort to achieve health equity
👉 What patients need to be aware of and what can they do to help themselves
👉 The role of the FDA and what regulators can and should be doing

The podcast is available through the links below:

️ ️ 〰️ Spotify: https://lnkd.in/dRrSEyn

️ ️ 〰️ Apple: https://lnkd.in/egSthAz

️ ️ 〰️ Stitcher: https://lnkd.in/eqB-2wb

📣 Now on YouTube 📣

Please subscribe: https://www.youtube.com/channel/UCS7XTUuk1XF5Tm5InADY6cA 

📣 Now on Instagram 📣

Please subscribe: 

https://www.instagram.com/msl_talk_podcast/ 

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversation and medical affairs discussions.

#msl #medicalaffairs #medicalscienceliaison #MSLTalk #pharmaceutical

(0:00) Introduction and sponsor mention: h one
(1:02) Ariel Katz introduction and overview of h one
(2:30) Ariel Katz's background, company mission, and health equity definition
(5:19) Causes of healthcare inequity and FDA's role
(9:53) MSLs' and leadership's role in achieving health equity
(13:38) Pharma companies' actions and importance of patient advocacy
(19:00) Stricter FDA regulations and MSLs' future engagement criteria
(23:36) Engagement with low and middle-income communities and Pfizer's new RFP
(26:03) Leadership, raising MSL awareness, and trust in healthcare
(27:35) Final thoughts from Ariel Katz
(28:03) Sponsor: H1
(28:22) Closing remarks and listener appreciation